Reliance Medical Systems Introduce the EndoPAT™ for Proactive Cardiac Risk Assessment
The Woodlands, TX, September 21, 2012 --(PR.com)-- Leading provider of innovative medical solutions, Reliance Medical Systems has recently announced the addition of the EndoPAT™ device to their broad-ranging catalogue. The EndoPAT™ solution has been designed to ensure fast and effective non-invasive assessment of endothelial function for patients at risk of potentially deadly cardiac issues.
Cardiac patients are often measured by Framingham Risk Score to determine the likelihood of them suffering adversely from cardiac events in the near future. But oftentimes, this type of diagnostic method is not enough to ensure complete patient health. In fact, studies show that patients who were assessed with low scores on the Framingham scale experienced 300% more adverse cardiac events over a 7-year period when they also have endothelial dysfunction. This shows that a more precise method of analysis is required. This study was conducted by Mayo Clinic and Tufts University and published in the European Health Journal.
The EndoPAT™ is the ideal cardiac risk assessment tool for the modern patient. The product is intuitive to use, and assessments can be conducted in-office in just 15 minutes by a trained medical professional. The EndoPAT™ tool works to recognize endothelial dysfunction, a problem which is often reversible and completely treatable. It measures endothelium-mediated changes in vascular tone using unique bio-sensors placed on the fingertips. Measurements elicited from the contra-lateral arm are used as a control for concurrent non-endothelial dependent changes in vascular tone. The automatically calculated result is an index of endothelial function.
The EndoPAT’s™ user-friendly design means that results are available within just a few minutes. The industry is now recognizing this solution as one of the leading methods for endothelial function assessment, and the product has now appeared in over 200 peer reviewed articles and journals produced by highly respected medical professionals.
To learn more about the innovative EndoPAT™ product, please visit the Reliance Medical Systems website at www.reliancemedicalsystems.com.
Cardiac patients are often measured by Framingham Risk Score to determine the likelihood of them suffering adversely from cardiac events in the near future. But oftentimes, this type of diagnostic method is not enough to ensure complete patient health. In fact, studies show that patients who were assessed with low scores on the Framingham scale experienced 300% more adverse cardiac events over a 7-year period when they also have endothelial dysfunction. This shows that a more precise method of analysis is required. This study was conducted by Mayo Clinic and Tufts University and published in the European Health Journal.
The EndoPAT™ is the ideal cardiac risk assessment tool for the modern patient. The product is intuitive to use, and assessments can be conducted in-office in just 15 minutes by a trained medical professional. The EndoPAT™ tool works to recognize endothelial dysfunction, a problem which is often reversible and completely treatable. It measures endothelium-mediated changes in vascular tone using unique bio-sensors placed on the fingertips. Measurements elicited from the contra-lateral arm are used as a control for concurrent non-endothelial dependent changes in vascular tone. The automatically calculated result is an index of endothelial function.
The EndoPAT’s™ user-friendly design means that results are available within just a few minutes. The industry is now recognizing this solution as one of the leading methods for endothelial function assessment, and the product has now appeared in over 200 peer reviewed articles and journals produced by highly respected medical professionals.
To learn more about the innovative EndoPAT™ product, please visit the Reliance Medical Systems website at www.reliancemedicalsystems.com.
Contact
Reliance Medical Supplies
Buck Fechik
(281) 364-8822
www.RelianceMedical.com
Contact
Buck Fechik
(281) 364-8822
www.RelianceMedical.com
Categories